NDC 70518-4516-01 - Lisinopril and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4516
- Requested NDC
- 70518-4516-01
- Package NDCs from labels
- 70518-4516-0, 70518-4516-1, 70518-4516-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, USP for oral use Rx Only | REMEDYREPACK INC. | 2026-09-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4516-0 | Lisinopril and Hydrochlorothiazide | 30 in 1 BLISTER PACK | TABLET | 30 | 2 | |
| 70518-4516-1 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | c7ce5a69-1e07-4d52-b815-ce64ac3731ac | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | NCS HealthCare of KY, LLC dba Vangard Labs | 43fa9a16-c112-419f-8d7b-177f580462f2 | 2024-09-23 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Rising Pharma Holdings, Inc. | 33f9c3ae-108d-469e-af6c-8be3b0f83139 | 2024-09-13 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril | LISINOPRIL | American Health Packaging | 50ae0dfe-d961-4bc0-9898-71f69f9a5403 | 2024-09-12 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril | LISINOPRIL | Camber Pharmaceuticals, Inc. | 387068e7-7fb9-44f3-ae1c-e45ebc755a3e | 2024-08-29 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| LISINOPRIL | LISINOPRIL | Solco healthcare U.S., LLC | e299d477-a612-4af4-b6aa-f5addc8a736d | 2024-08-27 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Bryant Ranch Prepack | cafb049d-724f-4daa-b210-4be2cc1e4e69 | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | ANDA076230 197885 E7199S1YWR 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | Bryant Ranch Prepack | 1ec55dd0-9ed5-40d2-978e-9fe773f2281a | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 98b97680-474c-4e70-89dd-15bb49773125 | 2024-08-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 3c9ceab1-75e9-47b0-a062-33d7d446b88a | 2024-08-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 3e35fb03-9173-6731-e054-00144ff8d46c | 2024-08-13 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 4c1a92c0-b491-4ae9-8bd0-029beb2b13c6 | 2024-08-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | cc58a6a5-5ccd-451c-837c-781d0a8da5cf | 2024-08-05 | Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | b78ad43f-f132-4f03-8c85-2cf9b3ab555b | 2024-07-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 1e02787f-ccb5-abc2-e063-6294a90af7c3 | 2024-07-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals, Inc. | 4aa518e1-d989-1fde-e054-00144ff88e88 | 2024-07-19 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals, Inc. | 4aa44af9-1aff-314c-e054-00144ff8d46c | 2024-07-19 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals, Inc. | 4af326db-bf2d-5310-e054-00144ff88e88 | 2024-07-19 | Boxed warning, Warnings, Adverse reactions | 197886 E7199S1YWR 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals,Inc. | 6f7f5697-acb0-ea95-e053-2991aa0ae7c7 | 2024-07-18 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| LISINOPRIL | LISINOPRIL | NuCare Pharmaceuticals,Inc. | 6314e49c-8715-2f01-e053-2a91aa0ab2a5 | 2024-07-18 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.